Outcome of AeroFact-treated infants and matched historical controls
| Part 1 | Part 2 | |||||
| AeroFact | Control | P value | AeroFact | Control | P value | |
| n | 10 | 30 | 21 | 63 | ||
| Primary outcomes, n (%) | ||||||
| Met study treatment failure criteria | 4 (40) | 11 (33) | 0.72 | 6 (29) | 30 (48) | 0.20 |
| Received instilled surfactant | 4 (40) | 14 (47) | >0.99 | 6 (29) | 29 (46) | 0.20 |
| Survived | 9 (90) | 30 (100) | 0.25 | 20 (95) | 63 (100) | 0.25 |
| Survived without BPD | 8 (80) | 22 (73) | >0.99 | 16 (76) | 43 (68) | 0.59 |
BPD, bronchopulmonary dysplasia.